Riverwater’s Post‑Reset Bet on CRAI Might Change The Case For Investing In CRA International (CRAI)

CRA International, Inc.

CRA International, Inc.

CRAI

0.00

  • In Q2 2026, Riverwater Partners used its Micro Opportunities Strategy investor letter to highlight CRA International (NASDAQ: CRAI), disclosing a larger position after a first‑quarter compensation reset that it believes should support improved results.
  • The letter argued that CRA International’s focus on profitable small businesses leaves its shares undervalued relative to consulting peers seen as beneficiaries of artificial intelligence trends.
  • We’ll now examine how Riverwater Partners’ view of CRA International’s undervaluation versus AI‑exposed consulting peers could influence its broader investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 56 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

CRA International Investment Narrative Recap

To own CRA International, you need to believe in steady demand for high value economic and legal consulting, especially in complex regulatory and M&A work. Riverwater Partners’ increased stake and focus on the Q1 2026 compensation reset reinforce the near term catalyst of potential margin recovery, but do not materially change the central risk that earnings remain sensitive to swings in deal and litigation activity.

Among recent announcements, the Q1 2026 results and reiterated 2026 revenue guidance of US$785 million to US$805 million matter most here, because they frame how any compensation reset may flow through to earnings over the rest of the year and interact with CRA’s ongoing share repurchases and dividend commitments.

Yet investors should also consider how CRA’s dependence on sustained M&A and regulatory activity could affect...

CRA International's narrative projects $890.9 million revenue and $74.0 million earnings by 2029. This requires 4.9% yearly revenue growth and about a $26.2 million earnings increase from $47.8 million today.

Uncover how CRA International's forecasts yield a $252.50 fair value, a 45% upside to its current price.

Exploring Other Perspectives

CRAI 1-Year Stock Price Chart
CRAI 1-Year Stock Price Chart

Two Simply Wall St Community fair value estimates for CRA International range from US$252.50 to US$336.85, underscoring how far opinions can spread. You can weigh these against the reliance on robust M&A and legal activity that could leave earnings exposed if corporate transactions slow, and decide which set of assumptions you find more convincing.

Explore 2 other fair value estimates on CRA International - why the stock might be worth just $252.50!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your CRA International research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
  • Our free CRA International research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate CRA International's overall financial health at a glance.

Searching For A Fresh Perspective?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

  • AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • Uncover the next big thing with 21 elite penny stocks that balance risk and reward.
  • Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.